SEC Form 4 · accession 0001209191-18-007238
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deborah M Reiner
Officer — SVP - Mktg. & Communications
Period of report
Jan 31, 2018
Accepted (ET)
Feb 2, 2018 · 7:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2018 | M | 5,000 | $22.95 | A | 7,020 | D | |
| Common Stock | Jan 31, 2018 | M | 6,525 | $47.97 | A | 13,545 | D | |
| Common Stock | Jan 31, 2018 | M | 3,000 | $68.96 | A | 16,545 | D | |
| Common Stock | Jan 31, 2018 | M | 1,495 | $69.58 | A | 18,040 | D | |
| Common Stock | Jan 31, 2018 | S | 2,020 | $102.00 | D | 16,020 | D | |
| Common Stock | Jan 31, 2018 | F | 9,475 | $101.16 | D | 6,545 | D | |
| Common Stock | Feb 2, 2018 | S | 6,545 | $101.54 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $22.95 | Jan 31, 2018 | M | 2,500 | D | — | Feb 8, 2022 | Common Stock | 2,500 | 0 | D |
| Stock Appreciation RightF3 | $22.95 | Jan 31, 2018 | M | 2,500 | D | — | Feb 8, 2022 | Common Stock | 2,500 | 0 | D |
| Stock Appreciation RightF4 | $47.97 | Jan 31, 2018 | M | 3,150 | D | — | Feb 5, 2024 | Common Stock | 3,150 | 0 | D |
| Stock Appreciation RightF5 | $47.97 | Jan 31, 2018 | M | 3,375 | D | — | Feb 5, 2024 | Common Stock | 3,375 | 1,125 | D |
| Stock Appreciation RightF6 | $68.96 | Jan 31, 2018 | M | 3,000 | D | — | Feb 4, 2025 | Common Stock | 3,000 | 3,000 | D |
| Stock Appreciation RightF7 | $69.58 | Jan 31, 2018 | M | 1,495 | D | — | Jan 29, 2026 | Common Stock | 1,495 | 4,485 | D |
| Stock Appreciation RightF8 | $101.16 | Jan 31, 2018 | A | 13,730 | A | Jan 31, 2019 | Jan 31, 2028 | Common Stock | 13,730 | 13,730 | D |
Explanation of responses
- F1The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
- F3The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
- F4The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
- F5The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.
- F6The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.
- F7The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.
- F8The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.